Ignite Creation Date:
2024-05-06 @ 6:30 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05681715
Status:
COMPLETED
Last Update Posted:
2024-05-23
First Post:
2023-01-04
Brief Title:
A Phase 3 Open-label Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis gMG
Sponsor:
Organization:
UCB Pharma